Compare GEF & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEF | APGE |
|---|---|---|
| Founded | 1877 | 2022 |
| Country | United States | United States |
| Employees | 12000 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | N/A | 2023 |
| Metric | GEF | APGE |
|---|---|---|
| Price | $68.01 | $90.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $73.33 | ★ $109.67 |
| AVG Volume (30 Days) | 183.6K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.73 | N/A |
| Revenue Next Year | $1.32 | N/A |
| P/E Ratio | $4.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.71 | $32.36 |
| 52 Week High | $77.14 | $89.69 |
| Indicator | GEF | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 70.44 |
| Support Level | $66.85 | $73.06 |
| Resistance Level | $69.90 | N/A |
| Average True Range (ATR) | 1.41 | 3.27 |
| MACD | 0.28 | 0.61 |
| Stochastic Oscillator | 43.72 | 97.86 |
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.